98%
921
2 minutes
20
The high fraction of -hybridized carbon atom (F ) character of cyclobutane derivatives renders them as highly promising bioisosteres for otherwise typically flat arenes. Here, to address the current needs in medicinal chemistry for F -rich molecules, we disclose a distinct strategy that exploits the merger of C-C scission in bicyclo[1.1.0]butanes (BCBs) with ruthenium-catalysed remote C-H functionalization of heteroarenes, affording densely substituted cyclobutanes in a chemo-controlled manner. This approach enabled the rapid and efficient synthesis of versatile tri- and tetrasubstituted cyclobutanes by coupling a wide range of mono- or disubstituted BCBs with heteroarenes and alkyl halides under mild reaction conditions, featuring ample substrate scope. The C-C/C-H functionalization was ensured by a multifunctional ruthenium(II) catalyst that enabled ruthenacycle-mediated halogen-atom transfer (Ru-XAT), as well as the selective functionalization of BCBs by strain release. Experimental and computational mechanistic studies unravelled a multi-catalysis manifold, while the C-H/C-C functionalization strategy allowed for telescoping late-stage modification.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12075002 | PMC |
http://dx.doi.org/10.1038/s44160-025-00745-3 | DOI Listing |
Nat Synth
February 2025
Wöhler-Research Institute for Sustainable Chemistry, Georg-August-Universität Göttingen, Göttingen, Germany.
The high fraction of -hybridized carbon atom (F ) character of cyclobutane derivatives renders them as highly promising bioisosteres for otherwise typically flat arenes. Here, to address the current needs in medicinal chemistry for F -rich molecules, we disclose a distinct strategy that exploits the merger of C-C scission in bicyclo[1.1.
View Article and Find Full Text PDFNat Commun
April 2024
Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Catalysed C-H activation has emerged as a transformative platform for molecular synthesis and provides new opportunities in drug discovery by late-stage functionalisation (LSF) of complex molecules. Notably, small aliphatic motifs have gained significant interest in medicinal chemistry for their beneficial properties and applications as sp-rich functional group bioisosteres. In this context, we disclose a versatile strategy with broad applicability for the ruthenium-catalysed late-stage meta-C(sp)-H alkylation of pharmaceuticals.
View Article and Find Full Text PDFChem Soc Rev
December 2017
Department of Chemistry, University of Bath, Claverton Down, Somerset, BA2 7AY, UK.
The search for selective C-H functionalisation has enabled some of the most elegant techniques in modern catalysis. Herein, we review the rapidly expanding field of ruthenium catalysed σ-activation as a tool in the selective meta-C-H functionalisation of arenes.
View Article and Find Full Text PDFNat Commun
June 2017
Institut für Organische und Biomolekulare Chemie, Georg-August-Universität Göttingen, Tammannstraße 2, 37077 Göttingen, Germany.